Merck & Co., Inc.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, LLY.DE has a market cap of 672.2B. Regarding current trading prices, 6MK.DE is priced at €70.00, while LLY.DE trades at €709.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas LLY.DE's P/E ratio is 66.17. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, JNJ.DE has a market cap of 326.5B. Regarding current trading prices, 6MK.DE is priced at €70.00, while JNJ.DE trades at €135.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas JNJ.DE's P/E ratio is 17.29. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, 6MK.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, 4AB.DE has a market cap of 294.6B. Regarding current trading prices, 6MK.DE is priced at €70.00, while 4AB.DE trades at €166.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas 4AB.DE's P/E ratio is 81.37. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, 6MK.DE is more volatile compared to 4AB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, ZEG.DE has a market cap of 199.6B. Regarding current trading prices, 6MK.DE is priced at €70.00, while ZEG.DE trades at €128.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas ZEG.DE's P/E ratio is 29.67. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, 6MK.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, AMG.DE has a market cap of 137.4B. Regarding current trading prices, 6MK.DE is priced at €70.00, while AMG.DE trades at €255.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas AMG.DE's P/E ratio is 26.71. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, 6MK.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, PFE.DE has a market cap of 121.5B. Regarding current trading prices, 6MK.DE is priced at €70.00, while PFE.DE trades at €21.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas PFE.DE's P/E ratio is 17.66. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, PFE.F has a market cap of 120.8B. Regarding current trading prices, 6MK.DE is priced at €70.00, while PFE.F trades at €21.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas PFE.F's P/E ratio is 17.57. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, GIS.DE has a market cap of 119.6B. Regarding current trading prices, 6MK.DE is priced at €70.00, while GIS.DE trades at €96.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas GIS.DE's P/E ratio is 23.00. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, 6MK.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, SNW.DE has a market cap of 105.5B. Regarding current trading prices, 6MK.DE is priced at €70.00, while SNW.DE trades at €86.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas SNW.DE's P/E ratio is 17.35. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, 6MK.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, BRM.DE has a market cap of 88.8B. Regarding current trading prices, 6MK.DE is priced at €70.00, while BRM.DE trades at €43.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas BRM.DE's P/E ratio is 18.66. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, 6MK.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, BAYN.SG has a market cap of 27.3B. Regarding current trading prices, 6MK.DE is priced at €70.00, while BAYN.SG trades at €27.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, BAYN.DE has a market cap of 27.3B. Regarding current trading prices, 6MK.DE is priced at €70.00, while BAYN.DE trades at €27.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas BAYN.DE's P/E ratio is -8.36. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, IDP.DE has a market cap of 17.3B. Regarding current trading prices, 6MK.DE is priced at €70.00, while IDP.DE trades at €118.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas IDP.DE's P/E ratio is 13.39. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, 6MK.DE is priced at €70.00, while GS7.DE trades at €20.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.